BIO

Bio-Rad Laboratories, Inc.Class A

368.55

USD

-0.77

-0.21%

Sep 14, 15:59 UTC -4

Closed

After-Market

369.02

+0.47

+0.13%

Bio-Rad Laboratories, Inc.Class A Profile

About

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.

Info & Links

CEO

Norman Schwartz

Headquarters

1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547, UNITED STATES

Auditor

KPMG LLP

Share holders

217

Employees

7,450

Bio-Rad Laboratories, Inc.Class A Statistics

Valuation Measures

Market Capitalization²

9.87B

Enterprise Value

10.55B

Enterprise Value/EBITDA(ttm)

198.75

Price to Earnings Ratio(ttm)

39.80

Price to Sales(ttm)

3.81

Price to Book(mrq)

1.38

Price to Cash(ytd)

36.85

Profitability

Gross Margin(ttm)

51.94%

Operating Margin(ttm)

9.64%

Profit Margin(ttm)

4.88%

Return on Equity(ttm)

3.54%

Return on Invested Capital(ttm)

1.78%

Return on Assets(ttm)

2.48%

Income Statement

Revenue(ttm)

2.59B

Revenue Per Share(ttm)

96.84

Gross Profit(ttm)

1.34B

EBITDA(ttm)³

53.10M

Net Income Available to Common(ttm)

222.40M

Diluted EPS(ttm)

8.25

Share Statistics

Beta (5Y Monthly)

1.07

52-Week Change

31.47%

S&P 500 52-Week Change

18.15%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

26.74M

Dividend Yield

0.00%

Float⁴

18.63M

% Held by Insiders

30.34%

% Held by Institutions

65.24%

Balance Sheet

Total Cash(mrq)

1.62B

Total Cash Per Share(mrq)

60.53

Total Debt(mrq)

1.20B

Total Debt/Equity(mrq)

16.78%

Current Ratio(mrq)

3.14%

Quick Ratio(mrq)

2.33%

Book Value Per Share(mrq)

268.30

Cash Flow

Operating Cash Flow Per Share(ytd)

7.71

Free Cash Flow(ytd)

144.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BIO